28 October 2020

Baroness Delyth Morgan, Chief Executive of Breast Cancer Now, said,

It’s is deeply concerning that 40% of charity-funded early career scientists have considered leaving research due to funding concerns due to COVID-19, and that over a quarter (28%) have considered leaving due to a lack of career prospects – yet another devastating blow due to the COVID-pandemic, and one with implications both now and for future generations, as these researchers hold the hope that medical research brings for so many in their hands.

We’ve experienced firsthand the impact of COVID-19 on breast cancer research with our researchers having lost around 230,000 hours in the labs, and much of our research has been put on pause due to the pandemic.

As medical research charities we collectively invested £1.9 billion in UK research and development (R&D) last year, and make a contribution that we simply cannot afford to be lost. For this reason we strongly back the call on the Government to introduce a Charity-Life Sciences Partnership Fund – as a co-investment scheme that would provide a level of match funding from Government for future charity research over the next three years, this Fund would not only be a crucial lifeline for charities that presses play on world-class research and saves lives, but would boost the UK’s economy by protecting its position as a global leader delivering excellence in the life sciences sector.